CYTEK BIOSCIENCES, INC. (CTKB) Total liabilities 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) total liabilities at each fiscal year-end, per SEC filings.
$119.8MFY2025 · since FY2020: $41.7M → $119.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $119.8M | +15.5% |
| FY2024 | $103.8M | +2.3% |
| FY2023 | $101.4M | +7.9% |
| FY2022 | $93.9M | +62.2% |
| FY2021 | $57.9M | +38.9% |
| FY2020 | $41.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating marginCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Shareholders’ equityCTKB overview →